Aspira Labs
Business Services · 1-10 Employees
View Company Info for Free
Overview
Website
www.aspiralabs.coRevenue
<$5 MillionIndustry
About Aspira Labs
Is Aspira Labs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Aspira Labs has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Aspira Labs recently announced quarterly report
Click to see if Aspira Labs had a recent Job posting/layoffs
Aspira Labs, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Aspira Labs
Funding: Get notified immidiatlly once Aspira Labs has new funding data
Product Launch: Get notified when Aspira Labs launches new products
Check out if Aspira Labs is spiking on competitors!
Recommended Actions
Find VP level buyers at Aspira Labs
Find 2 more new buyers
Aspira Labs Tech Stack
A closer look at the technologies used by Aspira Labs
Aspira Labs News & Media
BRIEF-Aspira Women'S Health Inc. Announces Equity Financing Of Approximately $11 Million
Aspira Women's Health Inc:Vermillion Inc. Announces ASPiRA LABS Now Credentialed as Florida State Medicaid Provider
Fourth largest Medicaid population in the U.S. Fourth largest Medicaid population in the U.S.Vermillion Announces Cigna Preferred Contract Coverage for OVA1, Overa and Genetics Testing
AUSTIN, Texas, March 27, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ: VRML), a bioinformatics-based women’s health company focused on gynecologic disease, announced yesterday that its wholly owned subsidiary, ASPiRA Labs, has signed a national preferred agreement with Cigna. This contract includes OVA1, (Multivariate Index Assay, MIA) our ACOG endorsed ovarian cancer risk assessment test, as well as Overa and all genetic testing offered by ASPiRA. This agreement with Cigna will expand ASPiMarket for Electrophysiology (EP) Medical Devices Continues to Grow due to Rise in Cardiovascular Diseases
PALM BEACH, Florida, November 2, 2017 /PRNewswire/ -- According to Transparency Market Research, The global electrophysiology devices market was valued at USD $2,500 million in 2012 and is expected to reach USD $5,496.6 million by 2019, growing at a CAGR of 12.1% from 2013 to 2019....
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aspira Labs
Aspira Labs is a specialized web agency that designs, builds, and manages high-converting websites exclusively for healthcare and wellness practices. They serve independent practices and growing wellness groups nationwide, focusing on turning online searches into booked patients. Their services include strategy, design, development, and launch, ens... Read More